The association of current hormonal contraceptive use with type-specific HPV detection

Sex Transm Infect. 2011 Aug;87(5):385-8. doi: 10.1136/sextrans-2011-050005.

Abstract

Background: Increased duration of hormonal contraceptive (HC) use may be positively associated with the risk of invasive cervical cancer.

Methods: This is a secondary analysis from the HPV Sentinel Surveillance Study. The authors examined the association between type-specific human papillomavirus (HPV) detection and current HC use among 7718 women attending 26 sexually transmitted disease, family planning and primary care clinics in the USA.

Results: There was an association between HC use and HPV-16 detection (adjusted prevalence rate ratio 1.34 (95% CI 1.05 to 1.71) for oral contraceptive users and 1.41 (1.01 to 2.04) for depot-medroxyprogesterone acetate users); there was no association between HC use and detection of other HPV types or any HPV overall.

Conclusions: Longitudinal studies are needed to better define this type-specific association and its clinical significance.

Publication types

  • Multicenter Study
  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Coitus
  • Contraceptive Agents, Female / adverse effects*
  • Cross-Sectional Studies
  • Female
  • Human papillomavirus 16*
  • Humans
  • Medroxyprogesterone Acetate / adverse effects*
  • Middle Aged
  • Papillomavirus Infections / chemically induced*
  • Risk Factors
  • Sentinel Surveillance
  • Sexual Partners
  • Uterine Cervical Dysplasia / virology
  • Young Adult

Substances

  • Contraceptive Agents, Female
  • Medroxyprogesterone Acetate